Gene · 2017
Papers4,431
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 4,431
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Functional Classification and Interaction Selectivity Landscape of the Human SH3 Domain Superfamily. | Cells | 2024 | 38275820 | PubTator, text mining | PubMed |
| Stiffness promotes cell migration, invasion, and invadopodia in nasopharyngeal carcinoma by regulating the WT-CTTN level. | Cancer Sci | 2024 | 38273817 | PubTator, text mining | PubMed |
| Cortactin stabilizes actin branches by bridging activated Arp2/3 to its nucleated actin filament. | Nat Struct Mol Biol | 2024 | 38267598 | PubTator, text mining | PubMed |
| Collagen I-induced VCAN/ERK signaling and PARP1/ZEB1-mediated metastasis facilitate OSBPL2 defect to promote colorectal cancer progression. | Cell Death Dis | 2024 | 38267463 | PubTator, text mining | PubMed |
| Mass production of iPSC-derived platelets toward the clinical application. | Regen Ther | 2024 | 38260088 | PubTator, text mining | PubMed |
| Exo70 Promotes the Invasion of Pancreatic Cancer Cells via the Regulation of Exosomes. | Cancers (Basel) | 2024 | 38254825 | PubTator, text mining | PubMed |
| Liver sinusoidal endothelial cells as potential drivers of liver fibrosis (Review). | Mol Med Rep | 2024 | 38240102 | PubTator, text mining | PubMed |
| Construction of an abnormal glycosylation risk model and its application in predicting the prognosis of patients with head and neck cancer. | Sci Rep | 2024 | 38225277 | PubTator, text mining | PubMed |
| Cortactin is in a complex with VE-cadherin and is required for endothelial adherens junction stability through Rap1/Rac1 activation. | Sci Rep | 2024 | 38216638 | PubTator, text mining | PubMed |
| Targeting cholesterol impairs cell invasion of all breast cancer types. | Cancer Cell Int | 2024 | 38200575 | PubTator, text mining | PubMed |
| Therapeutic strategy using novel RET/YES1 dual-target inhibitor in lung cancer. | Biomed Pharmacother | 2024 | 38198957 | PubTator, text mining | PubMed |
| Groebke Blackburn Bienaymé-mediated multi-component synthesis of selective HDAC6 inhibitors with anti-inflammatory properties. | Bioorg Chem | 2024 | 38185013 | PubTator, text mining | PubMed |
| ACY-241, a histone deacetylase 6 inhibitor, suppresses the epithelial-mesenchymal transition in lung cancer cells by downregulating hypoxia-inducible factor-1 alpha. | Korean J Physiol Pharmacol | 2024 | 38154967 | PubTator, text mining | PubMed |
| A synergistic regulation works in matrix stiffness-driven invadopodia formation in HCC. | Cancer Lett | 2024 | 38145655 | PubTator, text mining | PubMed |
| Requirement of Site-Specific Tyrosine Phosphorylation of Cortactin in Retinal Neovascularization and Vascular Leakage. | Arterioscler Thromb Vasc Biol | 2024 | 38126170 | PubTator, text mining | PubMed |
| Direct observation of cortactin protecting Arp2/3-actin filament branch junctions from GMF-mediated destabilization. | Eur J Cell Biol | 2024 | 38071835 | PubTator, text mining | PubMed |
| Current status and perspectives of genetic testing in gastrointestinal cancer (Review). | Oncol Lett | 2024 | 38058469 | PubTator, text mining | PubMed |
| Combined RNAi of CTTN and FGF2 Modulates Cell Migration, Invasion and G1/S Transition of Hepatocellular Carcinoma through Ras/ERK Signaling Pathway. | Curr Cancer Drug Targets | 2024 | 38031266 | PubTator, text mining | PubMed |
| ORAOV1, CCND1, and MIR548K Are the Driver Oncogenes of the 11q13 Amplicon in Squamous Cell Carcinoma. | Mol Cancer Res | 2024 | 37930255 | PubTator, text mining | PubMed |
| Combined Vorinostat and Chloroquine Inhibit Sodium-Iodide Symporter Endocytosis and Enhance Radionuclide Uptake In Vivo. | Clin Cancer Res | 2024 | 37921808 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2017/papers?page=9